The Direct Economic Cost of Pharmacologically-Treated Diabetes in Italy-2006. The ARNO Observatory

Marchesini, Giulio; Forlani, G.; Rossi, Elisa; A, Berti; Rosa, Marisa De

doi:10.1016/j.numecd.2009.10.009

Cited by 40 publications

(26 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our data showed that the yearly per patient cost in 2014 was 2,349 €. These figures are higher than those reported in other studies [22, 23]. This could be partly explained by the fact that we analyzed exclusively elderly patients.…”

Section: Discussioncontrasting

confidence: 73%

Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

Orlando¹,

Guerriero²,

Putignano³

et al. 2015

CDR

View full text Add to dashboard Cite

The treatment of diabetes in the elderly is a major challenge both in terms of clinical management and of public health. Evidence about prescribing patterns in the elderly diabetic population is limited. The aim was to describe trends in antidiabetic drug (AD) utilization patterns in the elderly in Southern Italy with a focus on drugs for cardiovascular prevention and pharmaceutical costs. The data used for this study were obtained from pharmacy records of Caserta Local Health Authority, a province in Southern Italy with 1 million of inhabitants, comprising urban and rural areas. Subjects above 65 years who received at least one dispensing of antidiabetic between January 2010 and December 2014 were selected. Prevalence and incidence rates (%) of AD use were calculated for each calendar year and stratified by class therapy and age group. Sub-analyses by cardiovascular co-medication therapy and pharmaceutical cost analysis were performed. The prevalence rate decreases from 22.0% in 2010 to 17.5% in 2014 (p<0.001). Proportion of subjects treated with monotherapy increases over the study period (33.9% in 2010; 38.6% in 2014; p<0.001). In particular, increases the proportion of users of metformin (18.2% in 2010; 23.7% in 2014; p<0.001), while the proportion of users of sulfonylureas dropped (11.0% in 2010; 7.2% in 2014; p< 0.001). About 90% of elderly diabetic patients are treated with drugs for cardiovascular prevention. The per/patient/yearly drug costs were 2,349 €: 28.5% for AD therapy and 71.5% for other treatments. Trend in drug utilization patterns showed a tendency towards treatment recommendations in older adults.

show abstract

Section: Discussioncontrasting

confidence: 73%

Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

Orlando¹,

Guerriero²,

Putignano³

et al. 2015

CDR

View full text Add to dashboard Cite

show abstract

“…Activity impairment and perception A er 1 year of treatment the annual number of h per patient missed for the disease management decreased by 56% 11.7% of patients (n = 123) lost on average 501 h in the year before and 206 h during the 1-year follow-up The assessment of direct healthcare costs is lower also than in previous observational studies [29]. As the study did not consider the cost of drugs, it is not fully consistent with a previous assessment of the economic impact of the introduction of vildagliptin, both alone and in fixed combination with metformin, on healthcare expenditure for T2DM patients in Italy [30].…”

Section: Methodsmentioning

confidence: 74%

Effects of Vildagliptin/Metformin Therapy on Patient-Reported Outcomes: Work Productivity, Patient Satisfaction, and Resource Utilization

Genovese

Tedeschi

2013

Adv Therapy

View full text Add to dashboard Cite

show abstract

“…We investigated quality of care indicators in a large, representative multiregional population-based cohort of people (the ARNO Observatory) living in four Italian regions (2 million inhabitants), assessing process indicators and hospital admissions as outcome indicators (1). Diabetic individuals were identified in 2010 through record linkage among prescriptions, hospital admissions, and local diabetes registries.…”

mentioning

confidence: 99%

Quality of Diabetes Care in Italy: Information From a Large Population-Based Multiregional Observatory (ARNO Diabetes)

et al. 2012

View full text Add to dashboard Cite

The Direct Economic Cost of Pharmacologically-Treated Diabetes in Italy-2006. The ARNO Observatory

Cited by 40 publications

References 19 publications

Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

Effects of Vildagliptin/Metformin Therapy on Patient-Reported Outcomes: Work Productivity, Patient Satisfaction, and Resource Utilization

Quality of Diabetes Care in Italy: Information From a Large Population-Based Multiregional Observatory (ARNO Diabetes)

Contact Info

Product

Resources

About